查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1785860

全球血液检测市场

Blood Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 206 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球血液检测市场规模将达到 1,431 亿美元

全球血液检测市场规模预计在2024年达到933亿美元，预计在2024-2030年的分析期内将以7.4%的复合年增长率增长，到2030年将达到1431亿美元。血糖检测是本报告分析的细分市场之一，预计其复合年增长率将达到7.2%，到分析期结束时规模将达到262亿美元。糖化血红素（A1C）检测细分市场在分析期间的复合年增长率预计将达到6.8%。

美国市场规模估计为 254 亿美元，中国市场预计复合年增长率为 11.4%

美国血液检测市场规模预计在2024年达到254亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到299亿美元，在2024-2030年的分析期间内，复合年增长率为11.4%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.8%和7.1%。在欧洲，预计德国市场的复合年增长率为4.9%。

全球血液学检测市场—主要趋势与驱动因素摘要

为什么血液检测成为现代医疗保健的重要组成部分？

血液检测是医疗保健领域最基本的诊断程序之一，能够提供关键讯息，了解患者的整体健康状况、疾病状态和治疗反应。从常规筛检到复杂的生物标记分析，血液检测用于诊断感染疾病、代谢障碍、心血管疾病、癌症和自体免疫疾病。慢性病的增加、预防保健意识的增强以及诊断技术的进步，正在推动医院、诊断实验室和照护现场对血液检测的需求。

COVID-19 疫情进一步凸显了快速、精准血液检测的重要性，促使人们增加对诊断基础设施的投资，并采用 PCR 检测和血清学检测等先进技术。此外，个人化医疗和精准诊断扩大了血液检测在指导标靶治疗的作用，尤其是在肿瘤和遗传疾病领域。随着医疗保健持续转向早期疾病检测和预防保健，对快速、精准、微创血液检测解决方案的需求预计将大幅增加。

科技进步如何改变血液检测？

血液检测技术的关键创新提高了准确性、速度和便利性，使患者和医疗保健提供者更容易获得诊断。该领域最具突破性的进展之一是液态切片技术的开发。液态切片能够透过血液中的循环肿瘤DNA (ctDNA) 和生物标记检测癌症和其他疾病。液态切片为传统组织切片检查提供了一种非侵入性替代方案，可实现早期癌症检测、疾病监测和治疗反应评估。

血液检测的另一个突破是照护现场(POC) 和家用血液检测设备的出现。这些可携式、用户友好的系统无需完整的实验室设置即可快速检测血糖、胆固醇、感染疾病和凝血水平。此外，人工智慧 (AI) 和机器学习 (ML) 正在整合到诊断平台中，以增强测试解读、改进预测分析并减少诊断错误。微流体和实验室晶片技术的采用也简化了样本处理，能够以最少的样本量进行快速、自动化的血液分析。这些技术进步不断发展，透过实现更快、更准确的诊断和更以患者为中心的医疗保健，改变了医疗格局。

哪些市场趋势将推动血液检测产业的成长？

对预防性医疗保健和定期体检的日益重视是推动血液检测市场发展的最重要趋势之一。随着糖尿病、心血管疾病和肝损伤等文明病率不断上升，越来越多的人选择定期进行血液检测，以便及早发现和评估风险。直销 (DTC) 服务的日益普及也推动了市场的发展，这些服务允许消费者无需医生转诊即可在线订购检测。这些服务允许在家中采集样本并以数位化方式解读结果，为注重健康的消费者提供了更大的便利性和可及性。

影响市场的另一个关键趋势是基于基因和生物标记的血液检测的扩展。随着精准医疗的日益普及，血液检测正被用于识别疾病的遗传易感性、指导标标靶治疗以及监测病情进展。此外，远端医疗和远端患者监护的兴起正在加速连网血液检测设备的普及，这些设备可与数位健康平台同步，实现即时追踪和医生咨询。全球对感染疾病监测的日益关注，包括抗菌素抗药性等新兴威胁，也推动了对快速、高通量血液检测解决方案的需求。

影响血液学检测市场未来发展的关键成长动力有哪些？

血液检测市场的成长受到多种关键因素的推动，包括疾病的流行、诊断技术的进步以及医疗保健投资的增加。其中一个主要成长要素是慢性病和感染疾病的发生率不断上升，这推动了对早期准确诊断的需求。世界各国政府和医疗保健组织都将疾病预防和早期疗育介入放在首位，这导致常规血液检测在人口健康管理中的应用日益普及。

影响市场的另一个关键因素是日益转向分散式和居家式侦测解决方案。随着消费者对便利性和可近性的需求不断提升，诊断公司正在投资可携式、用户友好的血液检测设备，这些设备无需前往实验室即可快速获得结果。此外，数据分析和人工智慧驱动诊断技术的进步正在提高检测准确性，并实现针对各种疾病的个人化风险评估和预测模型。随着全球医疗保健格局的不断发展，市场格局预计将因创新、健康意识的提升以及对更高效、更具成本效益的诊断解决方案的持续追求而扩大。

部分

测试类型（葡萄糖测试、A1C 测试、直接 LDL 测试、血脂检查、前列腺特异性抗原测试、COVID-19 测试、BUN 测试、维生素 D 测试、甲状腺刺激素(TSH) 测试、血清尼古丁/可替宁测试、高敏 CRP 测试、睾酮测试、ALT 测试、皮质醇测试、肌酐测试、AST 测试、其他血液测试、睪固酮测试、其他血液测试、研究血液测试、肌酸酐测试）

受访公司范例

  • Abbott Laboratories
  • ARUP Laboratories
  • Beckman Coulter
  • Becton, Dickinson and Company（BD）
  • Bio-Rad Laboratories
  • Cepheid
  • Charles River Laboratories
  • Eurofins Scientific
  • Genomic Health
  • Illumina
  • Labcorp（Laboratory Corp of America）
  • Myriad Genetics
  • Natera
  • PerkinElmer
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Thermo Fisher Scientific

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP29650

Global Blood Testing Market to Reach US$143.1 Billion by 2030

The global market for Blood Testing estimated at US$93.3 Billion in the year 2024, is expected to reach US$143.1 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Glucose Testing, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$26.2 Billion by the end of the analysis period. Growth in the A1C Testing segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$25.4 Billion While China is Forecast to Grow at 11.4% CAGR

The Blood Testing market in the U.S. is estimated at US$25.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$29.9 Billion by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Blood Testing Market - Key Trends & Drivers Summarized

Why Is Blood Testing Becoming More Essential in Modern Healthcare?

Blood testing is one of the most fundamental diagnostic procedures in healthcare, providing critical insights into a patient’s overall health, disease status, and treatment response. From routine screenings to complex biomarker analysis, blood tests are used for diagnosing infections, metabolic disorders, cardiovascular diseases, cancers, and autoimmune conditions. The increasing prevalence of chronic diseases, rising awareness of preventive healthcare, and advancements in diagnostic technology have fueled the demand for blood testing in hospitals, diagnostic laboratories, and point-of-care settings.

The COVID-19 pandemic further highlighted the importance of rapid and accurate blood testing, leading to increased investments in diagnostic infrastructure and the adoption of advanced technologies, such as PCR-based and serological tests. Additionally, personalized medicine and precision diagnostics have expanded the role of blood testing in guiding targeted therapies, particularly in oncology and genetic disorders. As healthcare systems continue to shift toward early disease detection and preventive care, the demand for fast, accurate, and minimally invasive blood testing solutions is expected to rise significantly.

How Are Technological Advancements Transforming Blood Testing?

Significant innovations in blood testing technology are enhancing accuracy, speed, and convenience, making diagnostics more accessible to patients and healthcare providers. One of the most transformative advancements in this field is the development of liquid biopsy technology, which enables the detection of cancer and other diseases through circulating tumor DNA (ctDNA) and biomarkers in the blood. Liquid biopsies offer a non-invasive alternative to traditional tissue biopsies, allowing for early cancer detection, disease monitoring, and treatment response evaluation.

Another breakthrough in blood testing is the emergence of point-of-care (POC) and home-based blood testing devices. These portable and user-friendly systems enable rapid testing for glucose, cholesterol, infectious diseases, and coagulation levels without requiring a full laboratory setup. Additionally, artificial intelligence (AI) and machine learning (ML) are being integrated into diagnostic platforms to enhance test interpretation, improve predictive analytics, and reduce diagnostic errors. The adoption of microfluidic and lab-on-a-chip technologies has also streamlined sample processing, enabling rapid and automated blood analysis with minimal sample volumes. As these technological advancements continue to evolve, they are revolutionizing the blood testing landscape, making diagnostics faster, more precise, and increasingly patient-centric.

Which Market Trends Are Driving Growth in the Blood Testing Industry?

The growing emphasis on preventive healthcare and routine screening is one of the most influential trends driving the blood testing market. With a rise in lifestyle-related conditions such as diabetes, cardiovascular diseases, and liver disorders, more individuals are undergoing regular blood tests for early detection and risk assessment. The increasing availability of direct-to-consumer (DTC) blood testing services, where individuals can order tests online without a physician’s referral, is also fueling market expansion. These services offer at-home sample collection and digital result interpretation, providing greater convenience and accessibility for health-conscious consumers.

Another key trend shaping the market is the expansion of genetic and biomarker-based blood tests. As precision medicine gains traction, blood testing is being used to identify genetic predispositions to diseases, guide targeted treatments, and monitor disease progression. Additionally, the rise of telemedicine and remote patient monitoring has accelerated the adoption of connected blood testing devices that sync with digital health platforms, enabling real-time tracking and physician consultations. The growing global focus on infectious disease surveillance, including emerging threats such as antimicrobial resistance, is also driving demand for rapid and high-throughput blood testing solutions.

What Are the Key Growth Drivers Shaping the Future of the Blood Testing Market?

The growth in the blood testing market is driven by several critical factors, including rising disease prevalence, advancements in diagnostic technology, and increasing healthcare investments. One of the primary growth drivers is the rising incidence of chronic and infectious diseases, which has led to an increased need for early and accurate diagnosis. Governments and healthcare organizations worldwide are prioritizing disease prevention and early intervention, leading to greater adoption of routine blood testing for population health management.

Another crucial driver shaping the market is the increasing shift toward decentralized and at-home testing solutions. As consumers demand greater convenience and accessibility, diagnostic companies are investing in portable, user-friendly blood testing devices that provide rapid results without the need for laboratory visits. Additionally, advancements in data analytics and AI-driven diagnostics are enhancing test accuracy, enabling personalized risk assessments and predictive modeling for various diseases. As the global healthcare landscape continues to evolve, the blood testing market is expected to expand, driven by innovation, increasing health awareness, and the continuous pursuit of more efficient, cost-effective diagnostic solutions.

SCOPE OF STUDY:

The report analyzes the Blood Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing, Thyroid-stimulating Hormone (TSH) Testing, Serum Nicotine/Cotinine Testing, High sensitivity CRP Testing, Testosterone Testing, ALT Testing, Cortisol Testing, Creatinine Testing, AST Testing, Others Blood Tests)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • ARUP Laboratories
  • Beckman Coulter
  • Becton, Dickinson and Company (BD)
  • Bio-Rad Laboratories
  • Cepheid
  • Charles River Laboratories
  • Eurofins Scientific
  • Genomic Health
  • Illumina
  • Labcorp (Laboratory Corp of America)
  • Myriad Genetics
  • Natera
  • PerkinElmer
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthineers
  • Sonic Healthcare
  • Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Blood Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Disease Burden Across Populations Throws the Spotlight on Preventive and Routine Blood Testing
    • Rising Demand for Early Diagnosis and Risk Stratification Propels Growth in Comprehensive Blood Testing Panels
    • Expansion of Point-of-Care Testing (POCT) Ecosystems Drives Decentralized Blood Testing Adoption
    • Technological Advancements in Microfluidics and Lab-on-Chip Devices Expand the Addressable Market for Rapid Testing Solutions
    • AI and Predictive Analytics Integration Strengthens the Business Case for Smart, Data-Driven Blood Diagnostics
    • Shift Toward Personalized and Precision Medicine Accelerates Demand for Biomarker-Based Blood Tests
    • Consumerization of Diagnostics Fuels Growth in At-Home Blood Testing Kits and Services
    • Proliferation of Telehealth Models Drives the Need for Seamless Remote Blood Testing Integration
    • Increased Utilization of Multiplex Testing Platforms Spurs Efficiency and Cost-Effectiveness in Labs
    • Growing Preference for Non-Invasive and Minimal Sample Volume Testing Sustains Demand for Capillary Blood Solutions
    • Public Health Initiatives and Screening Campaigns Generate Widespread Demand Across Demographic Segments
    • Rising Awareness of Lifestyle-Related Disorders Strengthens Market Uptake in Wellness and Preventive Health Sectors
    • Digital Health Integration and EHR Compatibility Propel Adoption of Connected Blood Testing Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Blood Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Glucose Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Glucose Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for A1C Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for A1C Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for A1C Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Direct LDL Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Direct LDL Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Direct LDL Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Lipid Panel Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Lipid Panel Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Lipid Panel Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Prostate-specific Antigen Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Prostate-specific Antigen Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Prostate-specific Antigen Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for COVID-19 Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for COVID-19 Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for BUN Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for BUN Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for BUN Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Vitamin-D Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Vitamin-D Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Vitamin-D Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Thyroid-stimulating Hormone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Thyroid-stimulating Hormone by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Thyroid-stimulating Hormone by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • JAPAN
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • CHINA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • EUROPE
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Blood Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • FRANCE
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • GERMANY
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 53: Germany Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Germany Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Germany 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Italy 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 59: UK Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: UK Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: UK 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 62: Spain Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Spain Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Spain 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 65: Russia Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Russia Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Russia 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 68: Rest of Europe Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Europe Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Europe 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 71: Asia-Pacific Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Asia-Pacific Historic Review for Blood Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Asia-Pacific 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 74: Asia-Pacific Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Asia-Pacific Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Asia-Pacific 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 77: Australia Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Australia Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Australia 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • INDIA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 80: India Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: India Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: India 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 83: South Korea Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: South Korea Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: South Korea 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 86: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Asia-Pacific Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Asia-Pacific 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 89: Latin America Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 90: Latin America Historic Review for Blood Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Latin America 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 92: Latin America Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Latin America Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Latin America 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 95: Argentina Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Argentina Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Argentina 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 98: Brazil Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Brazil Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Brazil 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 101: Mexico Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Mexico Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Mexico 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 104: Rest of Latin America Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Latin America Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Latin America 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 107: Middle East Recent Past, Current & Future Analysis for Blood Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 108: Middle East Historic Review for Blood Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Middle East 15-Year Perspective for Blood Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 110: Middle East Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Middle East Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Middle East 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 113: Iran Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Iran Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Iran 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 116: Israel Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Israel Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Israel 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 119: Saudi Arabia Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Saudi Arabia Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Saudi Arabia 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 122: UAE Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UAE Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UAE 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 125: Rest of Middle East Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Middle East Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Middle East 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030
  • AFRICA
    • Blood Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 128: Africa Recent Past, Current & Future Analysis for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Africa Historic Review for Blood Testing by Test Type - Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Africa 15-Year Perspective for Blood Testing by Test Type - Percentage Breakdown of Value Sales for Glucose Testing, A1C Testing, Direct LDL Testing, Lipid Panel Testing, Prostate-specific Antigen Testing, COVID-19 Testing, BUN Testing, Vitamin-D Testing and Thyroid-stimulating Hormone for the Years 2015, 2025 & 2030

IV. COMPETITION